Metrosouth Urology

Urologic Expertise and Care For You

Kidney Stones Predict Osteoporotic Fracture in CKD

February 27, 2019 Share this content: In a new study of patients with chronic kidney disease, the presence of kidney stones, compared with their absence, was significantly associated with a 2.3-fold increased risk of osteoporotic fracture Kidney stones predict an increased risk of osteoporotic fract...
Read More

Obesity Linked With Improved Survival in mCRPC

February 16, 2019 Share this content: Obese men treated with docetaxel for metastatic castration-resistant prostate cancer have longer cancer-specific and overall survival, a study found. SAN FRANCISCO—Obesity is associated with improved cancer-specific and overall survival among men with metastat...
Read More

Radium-223 Use in mCRPC Differs By Race

Copyright © 2018 Haymarket Media, Inc. All Rights ReservedThis material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions....
Read More

Metastatic Prostate Cancer Responds to Novel Radiation Therapy

February 15, 2019 This article originally appeared on Cancer Therapy Advisor. Share this content: By targeting prostate-specific membrane antigen, a molecule radiolabeled with lutetium-177 is expected to deliver high doses of beta radiation to distant metastases. SAN FRANCISCO — Treatment with a n...
Read More

Darolutamide Improves Metastasis-Free Survival in CRPC

February 14, 2019 Share this content: Median metastasis-free survival was longer with darolutamide than with placebo: 40.4 vs 18.4 months. Darolutamide, a new androgen-receptor antagonist, prolongs survival without metastases in men with nonmetastatic castration-resistant prostate cancer (CRPC) and ...
Read More